BioNTech SE ADR Falls Monday, Underperforms Market

Dow Jones2022-09-20

DJ BioNTech SE ADR Falls Monday, Underperforms Market

This article was automatically generated by MarketWatch using technology from Automated Insights.

The BioNTech SE ADR (BNTX) slipped 8.60% to $133.22 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.69% to 3,899.89 and the Dow Jones Industrial Average rising 0.64% to 31,019.68. BioNTech SE ADR closed $241.36 below its 52-week high ($374.58), which the company reached on November 29th.

The ADR underperformed when compared to some of its competitors Monday, as AbbVie Inc. $(ABBV)$ fell 0.97% to $142.66 and Amgen Inc. $(AMGN)$ fell 0.16% to $230.76. Trading volume (1.5 M) eclipsed its 50-day average volume of 849,476.

Data source: Dow Jones Market Data, FactSet. Data compiled September 19, 2022.

 

(END) Dow Jones Newswires

September 19, 2022 16:41 ET (20:41 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment